MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
- Published In:
- International journal of molecular sciences, 19(6) (2018)
- Authors:
- Jeong, Yu-On, Shin, Soo Jung, Park, Jun Yong, Ku, Bo Kyeong, Song, Ji Soo, Kim, Jwa-Jin, Jeon, Seong Gak, Lee, Sang Min, Moon, Minho
- Database ID:
- RPEP-03730
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03730APA
Jeong, Yu-On; Shin, Soo Jung; Park, Jun Yong; Ku, Bo Kyeong; Song, Ji Soo; Kim, Jwa-Jin; Jeon, Seong Gak; Lee, Sang Min; Moon, Minho. (2018). MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.. International journal of molecular sciences, 19(6). https://doi.org/10.3390/ijms19061800
MLA
Jeong, Yu-On, et al. "MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.." International journal of molecular sciences, 2018. https://doi.org/10.3390/ijms19061800
RethinkPeptides
RethinkPeptides Research Database. "MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related ..." RPEP-03730. Retrieved from https://rethinkpeptides.com/research/jeong-2018-mk0677-a-ghrelin-agonist
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.